HealthImmune Endotyping Identifies Four T2D Risk Subgroups
Immune-based endotyping has identified four distinct subgroups of type 2 diabetes (T2D) patients, each with unique risk profiles and inflammatory characteristics that can be therapeutically modified. This approach enables better risk stratification and personalized treatment strategies for T2D, as presented at EASD 2026.
European Medical Journal·4h ago



